These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28339378)

  • 1. Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions.
    Polonini HC; Loures S; de Araujo EP; Brandão MA; Ferreira AO
    Int J Pharm Compd; 2016; 20(5):426-434. PubMed ID: 28339378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of cholecalciferol, haloperidol, imipramine hydrochloride, levodopa/carbidopa, lorazepam, minocycline hydrochloride, tacrolimus monohydrate, terbinafine, tramadol hydrochloride and valsartan in SyrSpend SF PH4 oral suspensions.
    Polonini HC; Silva SL; Cunha CN; Brandão MA; Ferreira AO
    Pharmazie; 2016 Apr; 71(4):185-91. PubMed ID: 27209697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF.
    Geiger CM; Sorenson B; Whaley P
    Int J Pharm Compd; 2015; 19(5):420-7. PubMed ID: 26775449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4.
    Ferreira AO; Polonini H; da Silva SL; Aglio NCB; Abreu J; Fernandes BMA
    Int J Pharm Compd; 2017; 21(4):339-346. PubMed ID: 28719377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions.
    Polonini HC; Loures S; Lima LC; Ferreira AO; Brandão MA
    Int J Pharm Compd; 2016; 20(2):167-74. PubMed ID: 27323429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions.
    Ferreira AO; Polonini HC; Loures da Silva S; Cerqueira de Melo VA; de Andrade L; Brandão MAF
    Int J Pharm Compd; 2017; 21(3):255-263. PubMed ID: 28557789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4.
    Polonini H; da Silva SL; Cunha CN; Ferreira AO; Anagnostou K; Dijkers E
    Int J Pharm Compd; 2020; 24(3):252-262. PubMed ID: 32401746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions.
    Polonini HC; Silva SL; de Almeida TR; Brandão MAF; Ferreira AO
    Eur J Hosp Pharm; 2016 Nov; 23(6):352-358. PubMed ID: 31156882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend(®) SF PH4 oral suspensions.
    Ferreira AO; Polonini HC; Silva SL; Patrício FB; Brandão MAF; Raposo NRB
    J Pharm Biomed Anal; 2016 Jan; 118():105-112. PubMed ID: 26540625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4.
    Polonini H; da Silva SL; Brandão MAF; Bauters T; De Moerloose B; Ferreira AO
    Int J Pharm Compd; 2018; 22(6):516-526. PubMed ID: 30384353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of regularly prescribed oral liquids formulated with SyrSpend
    Uriel M; Gómez-Rincón C; Marro D
    Pharmazie; 2018 Apr; 73(4):196-201. PubMed ID: 29609685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of midazolam in syrspend SF and syrspend SF cherry.
    Geiger CM; Sorenson B; Whaley PA
    Int J Pharm Compd; 2013; 17(4):344-6. PubMed ID: 24261150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of Commonly Used Active Pharmaceutical Ingredients in a Ready-to-Use Oral Suspending Vehicle.
    Mansourian M; Dijkers E; Silva CCV; Polonini HC
    Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4.
    Espana B; Joseph-Tornabène F; Jaquet C; Perrot S; Prouillac C
    Int J Pharm Compd; 2020; 24(4):327-336. PubMed ID: 32649306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of rifampin in SyrSpend SF.
    Sorenson B; Whaley P
    Int J Pharm Compd; 2013; 17(2):162-4. PubMed ID: 23696177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations.
    Visser JC; Ten Seldam IEJ; van der Linden IJ; Hinrichs WLJ; Veenendaal RFH; Dijkers ECF; Woerdenbag HJ
    Int J Pharm Compd; 2018; 22(3):247-251. PubMed ID: 29878892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of propranolol hydrochloride in SyrSpend SF.
    Geiger CM; Voudrie MA; Sorenson B
    Int J Pharm Compd; 2012; 16(6):513-5. PubMed ID: 23259369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of captopril in SyrSpend SF.
    Geiger CM; Sorenson B; Whaley PA
    Int J Pharm Compd; 2013; 17(4):336-8. PubMed ID: 24261148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of vancomycin in SyrSpend SF.
    Whaley PA; Voudrie MA
    Int J Pharm Compd; 2012; 16(2):167-9. PubMed ID: 23050329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of gabapentin in SyrSpend SF.
    Sorenson B; Voudrie MA; Gehrig D
    Int J Pharm Compd; 2012; 16(4):347-9. PubMed ID: 23050395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.